Not suitable for treatment of infections caused by gm -ve non-fermenting bacteria. Not formulated for intracameral use. Discontinue immediately in case of severe hypersensitivity reactions. Caution in patients w/ history of non-severe hypersensitivity to other β-lactam agents & in patients who have experienced anaphylactic reaction to penicillin. May result in overgrowth of Candida, & prolonged use may result in overgrowth of other non-susceptible microorganisms (eg, enterococci &
Clostridium difficile) which may require interruption of treatment. Reports of mild to life-threatening antibacterial agent-associated pseudomembranous colitis. Medicinal products that inhibit peristalsis should not be given. Caution when co-administering cephalosporins at high dosage w/ potent diuretics (eg, furosemides) or aminoglycosides. Development of +ve Coombs' test may interfere w/ cross matching of blood. Slight interference w/ Cu reduction methods (Benedict's, Fehling's, Clinitest). False -ve result may occur in ferricyanide test. Consider Na content in patients on a controlled Na diet. Prescribe to pregnant women only if benefit outweighs the risk. Discontinue breast-feeding or discontinue/abstain from therapy.
Sign Out
